Member Info for CHELSEA7

cont:(

Creating higher therapeutic value
Access to substantial new funding together with a gradual relaxation of lockdown
conditions, should ensure Scancell can reverse delays that have been imposed on
its technological developments, core oncology programmes and therapeutic
evaluations. TPI considers the resource now provided will be sufficient for it to
generate meaningful clinical data that addresses unmet needs, including readouts (SCIB1 Phase 2 & Modi-1 Phase1/2 interim data) within the next 18 months,
while providing a cash runway for anticipated programmes beyond 2023.
Importantly in this respect, the Board considers it will be able to capture additional
value in a number of areas including, for example, its AvidiMab™ platform and
TaG antibodies, before needing to conclude licensing deals. Adding to this is the
ability to apply rapid application of its ImmunoBody® platform to the development
of a second generation COVID-19 vaccine, at a time when it is increasingly clear
that first generation products are neither likely to offer global panacea nor
convenient application, it is possible to recognise the scale of the opportunity
Redmile is seeking to capture.

And the worm is turning IMHO :( A 3rd Blue Day today could take us to 12.50/13p, bring it on.

Turner Pope Research Note............................

https://mcusercontent.com/d9ebd7c1aa0f3dbc5fab42eca/files/b06a222d-09d8-48ee-b6e5-f7d3d9c03f77/Scancell_Holdings_plc_19_11_2020_FINAL_BGv3.pdf

Scancell Holdings plc
The transformative phase of capital raising that Scancell has undertaken to
date in 2020 now appears to have drawn to a close. What is likely to be its
final stage, the Open Offer that Scancell made available to Qualifying
Shareholders on 12 October 2020, on the basis of 1 new ordinary share for
every 27 held, was declared unconditional on 5 November 2020, raising a
further c.£3.0 million gross at an issue price of 13p each. This permitted
existing shareholders to participate on the same basis as funds managed by
Redmile Group LLC (‘Redmile’), the US based specialist healthcare and life
sciences investment firm, that agreed a direct subscription for both new
Scancell ordinary shares and new Convertible Loan Notes (‘new CLNs’),
raising total gross proceeds of c.£30m. This represents a strong endorsement
of both the Company’s technology platforms and R&D pipeline. Together with
an end-September 2020 cash balance of c.£15.1m plus the £2m UKRI grant,
along with elimination of c.£4.25m debt following Vulpes Life Sciences Fund
(‘Vulpes’) and Redmile conversion of existing CLN holdings into equity as
announced on 26 October 2020 and 2 November 2020 resp., this leaves Scancell
well-resourced to deliver on stated development goals while also passing key
milestones on its route toward a number of medium-term inflection points,
any of which could potentially multiply its current valuation.
Use of Funds
The pool of funds now raised will allow Scancell to extend the utility of its
ImmunoBody®
, Moditope® and AvidiMab™/TaG antibody products and platforms,
while also accelerating and broadening its development pipeline of new potentially
novel therapies. It will provide flexibility regarding development plans for its
existing pipeline to ensure both optimal development and commercialisation
strategies can be pursued, thereby limiting the potential impact of economic
pressures caused by COVID-19. More specifically, while being expected to rapidly
move its COVID-19 DNA vaccine development programme forward, Scancell is
ideally positioned to progress its lead product, SCIB1, which has already initiated its
Phase II clinical study in melanoma, aiming to enrol a total of 25 patients, while
also completing the preparation of GMP supplies required for regulatory
submission to initiate Modi-1’s planned UK Phase I/II clinical study in H1 2021.
Creating higher therapeutic value
Access to substantial new funding together with a gradual relaxation of lockdown
conditions, should ensure Scancell can reverse delays that have been imposed on
its technological developments, core oncology programmes and therapeutic
evaluations.

Ivy, from your post earler on 2nd Generation vaccines........................

""3.Quicker and cheaper to scale up and manu which DNA is as compared to RNA.
Matti from Karolinska made point it will be harder to enrol older patients in particular due to roll out of Vax.""

If we were trying to find items out of the left field for news, I don"t think we would have to look too far past Karolinska. How many collaborations and sharing of mutal benefit has gone on between us and them over the last few years?? I would suggest many and that will only increase after we inject first patients into the MOD1 trial. Surely something will come from all of those years sharing ideas and potential?? I mention Moditope as in all those years time passes and we seem no nearer to working closely together on many issues, just another opportunity that is waiting to happen IMHO.

Fancy a good end to this week tomorrow, and very grateful to Vulpes for what they have done this week, the SP is ticking again freely and removing those 1m shares from the market at 10.50 has been so mutually beneficial, they have added more at a reasonable price, renewed interest from those waiting for a good time to build more and slowing down the sellers and the SP falls.

Not the greatest admirer of Zak Mir but he is going for 16p in January, and his articles are read by many, so another example where just a few words can become self fulfilling as we position ourselves for assaults on 20p in what should prove a very Pivotal Year. ATB to us all.

Ivyspivey, thanks for your input from the discussion today that included Sally Adams.

Just a couple of questions who was it that called the discussion and do you think its contents will have any effect on the Scancell SP. Of all the items for news coming next, I felt COVIDITY night provide for that, do you feel after listening today there is a chance that might be the case? Thanks

Was expecting one tonight but that certainly wasn"t there at 17.30 tonight, a 150k black tade at 12p.

In line with quite a few trades this week, nigh on impossible to call, one of those we might see a reaction too tomorrow instead.

So a volume today of 1.930m over 71 trades, we have been struggling to get 1m trades and 30/35 trades a day recently and the last couple of trades on NEX show how hard that trade is to call.......................

17-Dec-20 16:16:39 12.20 16,311 1,990 O
17-Dec-20 16:08:58 11.77 51,000 6,003 O

Hasiba, a good honest post from yesterday......................

hasiba

Posted in: SCLP

Posts: 3,708

Price: 11.25

No Opinion

RE: 37 Trades Today16 Dec 2020 15:51
I don’t trust sp rise on very low trade volumes but like drifting lower sp on low volumes when I want to buy!
Or I am getting it wrong here today...
Sclp looks great at any sp below the recent offer of 13p....in any case but I am going to wait for the news or sp reverse sentiment and trends...even if I will be adding at higher sp but more confident..
Now happy to hold strong ...

Result, you added 80k odd today at 12.30p!!!! Wonder what we will see tomorrow?? Volumes up, trades up, mind you loads of tiny trades at 12.50 but signs are good IMHO that for a fair few people with available funds they see now as a good time to buy more as the SP settles and sellers seem harder to come by. Just another 5% will take us nigh on short of 13p and news of almost any kind could take us over that level, which I feel reflects better the enrmity of what we have achieved by way of funding in 2020., jut IMHO

Good question WTP, well the trade was just cancelled whether that be for insufficient funds or any other reason the trade doesn"t stand, which to be blunt is just another sell less to acomodate.

Delighted with the SP performance today, we rose higher than yesterday on an increased volume, and as hasiba said that was a sign he was looking for and duly added 78k more at 11.30 as a result. Edging towards 13p for Xmas, ut picking up nicely from the recent fall, reasons to be ceerfull?? Yeah a few!!!

There we a few interesting buys to day from 230k to 130k x 2. Director buys? who knows but we will soon find out, unless we believe Vulpes have stopped increasing now for a while, which there is no particular evidence of.

Looking forward to tommorrow again, missed today largely but a nice 2nd day confirmation all the same as we head for the OO range and some. With the good things on funding in recent weeks 13p looke a more realistic price and a perfect launch pad for the new year, IMHO

Increasing nicely every day, trades up to nigh on 70 and average trades down from recent highs, Good to see 12.50 being paid on the ask again.

Afternoon LL well I said Mondoy I was hoping we did getnews, since 2012 we have had December news all but one year as per Rucks excellent chart, so thats two Director Buys in total 1m and I just hope the news we get, if any, is to do with COVIDITY, IT IS POSSIBLE, lets see ATB

100k sell at 12p cancelled immediately, no trade.

Slightly stronger taking into account the first Director Buys probably, we were a 4% buy!!!

I feel much the same about charts as I always have but understand them better now, they are by definition self fulfilling, and do not foresee latest news but like everything they are tool, a guide, and would be wrong to ignore. A good day again today.

13P FOR Xmas is getting nearer and say so all of us.!!

Well don hasiba, a second day confirmation higher than to day and 78k more in the top drawer.

A man of your word.

Morning Guys, a very welcome sight!!

Hmmm, another reason for kitchen towels!!

Ruck,

Are you taking your Primrose Oil?

What he hasn"t told you was he was selling at 17/18p whilst pumping the share to 26p going by the Barchart Scancell page.

Regardless what the current charts say, what they don"t tell you is that Vulpes have taken 1m shares which were hanging over the market. A good day +4.65% as a result of Vulpes having done so. Take care buddy, I warned yer.

WTP, Aimbig is winding you up, trying to make you look foolish, as he always does. Short term indicators are a sell.

43k

Traffic lights go Green,,,,,,,,,,,,5k

Afternoon Yardstick,

Well 11.40 has been paid 19 times now and normally I would expect to see a delayed sell once cleared.

Just the 5 sells today, total 175k, 1 of which was for 107k, and the bid hasn"t moved either, 11.222 for 100k and 260k+ at 11.089. Only been 8 trades since 12..ish